Skip to main content

Table 2 Assessment of pain intensity, cognition, disability, and insomnia between rehabilitation and ILIB treatment groups

From: Intravascular laser irradiation of blood as novel migraine treatment: an observational study

Variable

Pre-treatment

Post-treatment

1 month post-treatment

 

Rehab

ILIB

Rehab

ILIB

Rehab

ILIB

VAS for pain (mean ± SD)

4.89 (2.55)

5.07 (1.59)

3.33 (2.78)

2.63 (1.74)b

3.61 (2.69)

3.30 (2.32)c

MOCA (mean ± SD)

24.56 (5.34)

27.13 (2.03)

25.11 (5.09)

28.33 (1.18)b

25.67 (5.12)

28.60 (1.68)c

MIDAS (mean ± SD)

74.67 (74.17)

30.40 (33.29)

62.33 (56.04)

32.2 (50.82)

30.67 (31.85)

10.13 (18.62)c

AIS (mean ± SD)

8.67 (5.87)

8.06 (4.42)

6.78 (7.03)

3.60 (2.85)b

6.33 (4.44)

3.80 (4.16)a,c

  1. ILIB, intravascular laser irradiation of blood; VAS, Visual Analog Scale; MOCA, Montreal Cognitive Assessment; MIDAS, Migraine Disability Assessment; AIS, Athens Insomnia Scale
  2. aA p-value of < 0.05 was significant in the experiment group of 1 month post-ILIB compared to the control group of 1 month post-ILIB
  3. bA p-value of < 0.05 was significant in the experiment group of Psot-ILIB compared to the experiment group of Pre-ILIB
  4. cA p-value of < 0.05 was significant in the experiment group of 1 month psot-ILIB compared to the experiment group of Pre-ILIB